A Chimeric Signal Peptide-Galectin-3 Conjugate Induces Glycosylation-Dependent Cancer Cell-Specific Apoptosis.

MLA

Lee, Sok-Hyong, et al. “A Chimeric Signal Peptide-Galectin-3 Conjugate Induces Glycosylation-Dependent Cancer Cell-Specific Apoptosis.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 26, no. 11, June 2020, pp. 2711–24. EBSCOhost, https://doi.org/10.1158/1078-0432.CCR-18-3280.

APA

Lee, S.-H., Khwaja Rehman, F., Tyler, K. C., Yu, B., Zhang, Z., Osuka, S., Zerrouqi, A., Kaluzova, M., Hadjipanayis, C. G., Cummings, R. D., Olson, J. J., Devi, N. S., & Van Meir, E. G. (2020). A Chimeric Signal Peptide-Galectin-3 Conjugate Induces Glycosylation-Dependent Cancer Cell-Specific Apoptosis. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 26(11), 2711–2724. https://doi.org/10.1158/1078-0432.CCR-18-3280

Chicago

Lee, Sok-Hyong, Fatima Khwaja Rehman, Kari C Tyler, Bing Yu, Zhaobin Zhang, Satoru Osuka, Abdessamad Zerrouqi, et al. 2020. “A Chimeric Signal Peptide-Galectin-3 Conjugate Induces Glycosylation-Dependent Cancer Cell-Specific Apoptosis.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 26 (11): 2711–24. doi:10.1158/1078-0432.CCR-18-3280.